Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 10 Endometrial Neoplasms 9 Vulvar Neoplasms 3 Uterine Neoplasms 2 Ovarian Neoplasms 2 Sentinel Lymph Node Biopsy (SLNB) 1 Recurrence 1 Recurent Vulvar Carcinoma 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Cervical Adenocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1

Interventions

Carboplatin 19 Paclitaxel 17 Cisplatin 9 Cyclophosphamide 8 Gemcitabine 7 Bevacizumab 6 Topotecan 5 pembrolizumab 4 olaparib 4 liposomal doxorubicin 4 durvalumab 4 Letrozole 4 Interleukin-2 4 Drug Therapy 4 Doxorubicin 4 Albumin-Bound Paclitaxel 4 rucaparib 3 fludarabine 3 chiauranib 3 cemiplimab 3 camrelizumab 3 Therapeutics 3 Itraconazole 3 Injections 3 Hyperthermic Intraperitoneal Chemotherapy 3 Everolimus 3 pazopanib 2 iniparib 2 eprenetapopt 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sentinel Lymph Node Biopsy × Gynecologic × Clear all

NCT03719547 2025-07-01

RACC

Karolinska Institutet

Phase NA Recruiting

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡